Fresenius Medical Care AG & Co KGaA (FMEG.DE)
* CEO TELLS Q1 ANALYST CALL WE ARE LOOKING TO BE MORE ACTIVE IN THE ACQUISITION ARENA; IT'S SMALL THINGS Further company coverage: (Reporting By Berlin Newsroom)
April 23 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:
FRANKFURT U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $4.75 billion takeover agreement.
BERLIN German healthcare group Fresenius SE said it had decided to pull out of its planned acquisition of Akorn after it found data integrity breaches at the U.S. generic drug maker.
BERLIN German dialysis specialist Fresenius Medical Care cut its 2018 sales target due to lower than expected doses of calcimimetic drugs at its dialysis service business in the United States.
* Now sees 2018 revenue growth of 5-7 pct at constant currency
BERLIN German dialysis specialist Fresenius Medical Care is selling its majority shareholding in Sound Inpatient Physicians Holdings for $2.15 billion, it said on Saturday.
BERLIN, April 21 German dialysis specialist Fresenius Medical Care is selling its majority shareholding in Sound Inpatient Physicians Holdings for $2.15 billion euros, it said on Saturday.
* SAYS FOR 2018, CO EXPECTS REVENUE GROWTH OF AROUND 8 PERCENT AT CONSTANT CURRENCY
* SAYS ESTABLISHES PROVISION OF EUR 200 MILLION REGARDING ONGOING FCPA SETTLEMENT NEGOTIATIONS